Table 3. Patients’ characteristics comparison in the groups with standard (S) and extended (E) indications for VATS major pulmonary resection.
Group S (N45) | Group E [47] | P value | |
---|---|---|---|
Age | 58 [34-85] | 56 [23-87] | 0.581 |
Gender, male | 21 (46.7%) | 21 (44.7%) | 0.923 |
CCI | 2.6 | 3.4 | 0.097 |
BMI | 26.6 | 25.6 | 0.449 |
FEV1, % | 82 | 81 | 0.886 |
Diagnosis | 0.339 | ||
Lung cancer | 32 (71.1%) | 35 (74.5%) | |
Bronchoectasis | 3 (6.7%) | 6 (12.8%) | |
Tuberculomas | 4 (8.9%) | 2 (4.3%) | |
Lobe resected | 0.393 | ||
RUL | 20 (44.4%) | 19 (40.4%) | |
RML | 4 (8.9%) | 2 (4.3%) | |
RLL | 3 (6.7%) | 10 (21.3%) | |
LUL | 7 (15.6%) | 2 (4.3%) | |
LLL | 5 (11.1%) | 12 (25.5%) | |
Number of ports | 0.903 | ||
1 | 2 (4.4%) | 1 (2.1%) | |
2 | 8 (17.8%) | 15 (31.9%) | |
3 | 30 (66.7%) | 27 (57.4%) | |
4 | 5 (11.1%) | 4 (8.5%) |
CCI, Charlson co-morbidity index; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe;VATS, video-assisted thoracoscopic surgery.